Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-21

Clinical Trial Update: Dexmedetomidine in Postoperative Analgesia [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update indicates that dexmedetomidine is being studied for postoperative analgesia in Phase 2 and Phase 3, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE)

Snippet

Sponsor: New Valley University | Conditions: Pain Management | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION